| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 10, 2024 | May 13, 2024 | TREACE MEDICAL CONCEPTS, INC. | Director | Buy | 97.5 | +130,000 | 37.43% | ✗ | $594.6K |
| May 24, 2023 | May 26, 2023 | Neuronetics, Inc. | Director | Sell | 91.3 | +21,964 | 23.77% | ✓ | $38.9K |